Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closed to Accrual

The Canadian Cancer Trials Group AL.5 (DFCI 06-254) trial has met its accrual goal of 112 registered patients and is now closed to accrual. Canadian Cancer Trials Group sites contributed 34 patients to this trial, which represents 30% of the total accrual. The final Canadian patient is expected to complete treatment by November 2014.

Thanks to all participating centres, staff and patients for helping to bring this trial to a successful close.